Zhende Medical Co., Ltd. (SHA:603301)
20.90
+0.07 (0.34%)
Jun 9, 2025, 2:45 PM CST
Zhende Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 5,547 | 5,856 | 6,477 | 10,059 | 11,564 | 13,491 | Upgrade
|
Market Cap Growth | 6.99% | -9.58% | -35.61% | -13.02% | -14.29% | 343.05% | Upgrade
|
Enterprise Value | 5,691 | 5,978 | 5,723 | 9,327 | 10,827 | 11,949 | Upgrade
|
Last Close Price | 20.83 | 21.99 | 23.93 | 35.26 | 46.83 | 54.09 | Upgrade
|
PE Ratio | 15.35 | 15.21 | 32.64 | 14.80 | 19.41 | 5.29 | Upgrade
|
Forward PE | 14.17 | 12.67 | 9.13 | 11.70 | 18.82 | 19.82 | Upgrade
|
PS Ratio | 1.29 | 1.37 | 1.57 | 1.64 | 2.27 | 1.30 | Upgrade
|
PB Ratio | 0.93 | 0.99 | 1.16 | 1.75 | 2.61 | 3.02 | Upgrade
|
P/TBV Ratio | 1.32 | 1.41 | 1.63 | 2.23 | 3.59 | 3.53 | Upgrade
|
P/FCF Ratio | - | - | - | 20.45 | 94.66 | 6.65 | Upgrade
|
P/OCF Ratio | 13.63 | 12.70 | 14.33 | 8.07 | 14.14 | 4.32 | Upgrade
|
EV/Sales Ratio | 1.33 | 1.40 | 1.39 | 1.52 | 2.13 | 1.15 | Upgrade
|
EV/EBITDA Ratio | 9.48 | 9.76 | 12.02 | 9.34 | 12.61 | 3.21 | Upgrade
|
EV/EBIT Ratio | 15.80 | 15.94 | 24.53 | 11.47 | 14.89 | 3.28 | Upgrade
|
EV/FCF Ratio | -14.21 | - | - | 18.96 | 88.62 | 5.89 | Upgrade
|
Debt / Equity Ratio | 0.18 | 0.10 | 0.11 | 0.11 | 0.19 | 0.10 | Upgrade
|
Debt / EBITDA Ratio | 1.83 | 0.95 | 1.34 | 0.60 | 0.98 | 0.12 | Upgrade
|
Debt / FCF Ratio | - | - | - | 1.23 | 6.94 | 0.22 | Upgrade
|
Asset Turnover | 0.53 | 0.57 | 0.54 | 0.86 | 0.79 | 2.29 | Upgrade
|
Inventory Turnover | 3.62 | 3.63 | 3.30 | 4.61 | 3.51 | 7.37 | Upgrade
|
Quick Ratio | 1.34 | 1.50 | 1.54 | 1.98 | 1.31 | 1.75 | Upgrade
|
Current Ratio | 1.92 | 2.28 | 2.32 | 2.72 | 1.99 | 2.50 | Upgrade
|
Return on Equity (ROE) | 6.41% | 6.91% | 3.76% | 13.77% | 16.19% | 101.32% | Upgrade
|
Return on Assets (ROA) | 2.79% | 3.16% | 1.92% | 7.10% | 7.09% | 50.25% | Upgrade
|
Return on Capital (ROIC) | 3.20% | 3.68% | 2.31% | 8.72% | 8.90% | 64.41% | Upgrade
|
Return on Capital Employed (ROCE) | 5.50% | 5.80% | 3.80% | 12.70% | 15.10% | 78.20% | Upgrade
|
Earnings Yield | 6.54% | 6.58% | 3.06% | 6.76% | 5.15% | 18.90% | Upgrade
|
FCF Yield | -7.22% | -5.27% | -2.27% | 4.89% | 1.06% | 15.03% | Upgrade
|
Dividend Yield | 5.52% | 2.96% | 5.22% | - | 1.28% | 4.25% | Upgrade
|
Payout Ratio | 42.76% | 41.38% | 213.57% | 24.16% | 91.24% | 3.07% | Upgrade
|
Buyback Yield / Dilution | -0.17% | 0.92% | -13.18% | -4.56% | -11.08% | -4.00% | Upgrade
|
Total Shareholder Return | 5.35% | 3.88% | -7.95% | -4.56% | -9.80% | 0.25% | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.